PDFファイル - 医薬品医療機器総合機構
Contents
1.2.
3. ON
4. 1 2 3 1
5. BF
6. 1 1 RFA
7. 80 70 60 50 40 30 20 10 0 0 20 40 60 kJ 80 1 CT
8. RFA
9. 1cm
10. 3 3 1
11. RFA CelonLab POWER 10 1 1 RFA 2 RFA OFF
12. 4 1 6 17
13. 2
14. RFA 3 1
15. 1 7 15
16. 5 RFA
17. 2
18. 6 17
19. 2 3 2 3
20. 91 85 93 4 321 5 2 5 5 5 99 5 5 CRP 44 3 3 3 3 2 2 1 1 1 1 1 1 1 1 1 1 13 2 11 0 1 1 1 1 1 1 1 1 13 2 2 2 SpO gt 1 1 1 1 1 1 1 1 4 4 2 2 1 1 1 1 1 1 11 1 1 8 8
21. 1 30 1 4
22. RFA CelonLab POWER CelonAquaflow I SE 1 7 15 1
23. 2 13 15 1 10 3 91 85 93 4 321
24. OFF 25 C
25. 11 RFA 12 5 11 13 ON OFF 2 1 2 RFA ON 3 4 5 ON 6
26. k 1 1 1202001 1202001 RFA 17 12 2 2 0924003 0924001 16 9 24 3 11 17 4 26 4 0729 2 0729 1
27. mm mm i 2 WB990212 100 20 RY Ci WB990213 100 30 0 WB990214 100 40 4 6 WB990215 150 20 5 2 WB990216 150 30 a WB990217 150 40 0 ee WB990218 200 20 a WB990219 200 30 Mt i WB990220 200 40 WB990221 250 30 5 WB990222 250 40 1 8mm 3m 3 5m 2 20cm 3 1 7m 2 1 A 3 3 EMC EMC 2 EC 60601 1 2 200
28. 84 92 3 7 7 7 1 73 80 2 2 15 16 5 3 3 3 3 1cm 13 14 3 1 1 2cm 57 62 6 2 1 3cm 17 18 7 3 1 4cm 4 4 4 1 2 1 90 88 97 8 2 3 1 77 8 70790 8 1 1 54 2 24 2 86 7 78 90 9 2 2 54 3 16 77 8 70790 8 3 97 6 81 83 100 777 4
29. 192 8507 2951 TEL 0120 41 7149 OLYMPUS WINTER amp IBE GMBH 878 2012 OLYMPUS MEDICAL SYSTEMS CORP All rights reserved GE8426 04 Printed in Japan 20150825 O000
30. 7 3 1 OFF 2 3 RFA OFF 4 1 RFA 2 1
31. 27 7 29 5 2005 6 2005 2005 2 7 Kotoh K et al A multstep incremental expansion method for radiofreqduency ablation optimization of the procedure to prevent increaseSs In intra tumor pressure and to reduce the ablaton tme Liver International 2005 25 542 547 8 Tito Livraghi et al Treatment of Focal Liver Tumors with Percutaneous Radio frequency Ablaton Complications Encountered in a Multicenter Study Radiology 2003 226 2 441 451 9 2 2002 99 40 44 10 Joseph M Llovet et al Increased Risk of Tumor Seeding After Percutaneous Radiofrequency Ablation for Single Hepatocellular Carcinoma Hepatology 2001 33 1124 1129 11 TACE 65 2 2005 12 Kawasaki T et al Hepatocellular carcinoma that ruptured during radiofreduency ablation thera
32. 3 RFA 4 9 RFA ON RFA OFF 5 6 7 8 9 10
33. 10mm
34. OFF
35. 2 3 1 FX T20x1 T30x1 T30x2 20W 30W 60W 10kJ 15kJ 25kJ 13min 13min 17min 15mm 0 223 T30x3 T40x3 90W 120W 35kJ 70kJ 16min 19min RFA
36. 3 6 7 8 9 6 16 10 12 11 12 13 14 15 16 17 18 19 20 21 22 23 24 DIC 25 26 27
37. 254 79 1 67 20 9 80 o 5 AST ALT LDH ALP 4 4 1 4cm 3 1 4cm 4 6 6 2
38. 3 3cm 100 69 69 3cm 4cm 759 34 3cm 2 3 94 1 16717 5 88 24 80 98 TE4 100 99 0 97 98 6 CR 98 8 79780 7 6 5 7 5 87 ITT 3 1 1 2 2 2
39. NO MRI 1 RFA CelonPOWER 11 1
40. 3 3 6 6 PT 4 4 1 1 1 1 1 1 AST 79 1 ALT 5 8 1 1 1 1 1 1 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 91 1 5 90 91 22 0 LDH 24 2 3 3 ALP 5 5 BUN 1 1 1 1
41. 5 B 2cm A B 3cm 2 3 6 16 1 7 15 1 1 2 3 4 5
42. 2015 8 25 4 2014 12 12 3 22400BZX00269000 29 JMDN 36070000 RFA CelonPOWER
43. 1 RFA RCAP RCAP 1 RFA 2 2 3 RFA 15
44. py Joumal of Gastroenterology 2004 Oct 39 10 1015 6 13 Ryosuke Tateishi Shuichiro Shiina Takuma Teratani Shuntaro Obi Shinpei Sato Yukihiro Koike Tomonori Fujishima Haruhiko Yoshida Takao Kawabe Masao Omata Percutaneous Radiofreduency Ablation for Hepatocellular Carcinoma CANCER 2005 103 1201 1209 14 Takuma Teratani Haruhiko Yoshida Shuichiro Shiina Shuntaro Obi Shinpei Sato Ryosuke Tateishi Noro Mine Yuji Kondo Takao Kawabe Masao Omata Radiofrequency Ablation for Hepatocellular Carcinoma in So Called High Risk Locations HEPATOLOGY 2006 43 5 1101 1108 15 Dongil Choi Hyo K Lim Hyunchul Rhim Young sun Kim Won Jae Lee Seung Woon Paik Kwang Cheol Koh Joon Hyoek Lee Moon Seok Choi Byung Chul Yoo Percutaneous radiofreduency ablaton for eary stage hepatocellular carcinoma as a first line treatment long term results and prognostic factors in a large single institution series Eur Radiol 2007 17 684 692 16 2010 2009 11 17 2 2010 7 TEL 0120 41 7149
Download Pdf Manuals
Related Search